The purpose of this study was to determine the effects of cardiac resynchronization therapy (CRT) with respect to heart failure etiology among patients in the REVERSE (REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction) study.
Cardiac resynchronization therapy (CRT) improves symptoms, heart failure (HF) morbidity and mortality in New York Heart Association (NYHA) functional class III or IV patients with left ventricular (LV) dysfunction, and QRS prolongation (1) (2) (3) (4) . CRT also progressively improves LV function, suggesting that CRT might also delay disease progression in mildly symptomatic patients (5, 6 ). This hypothesis was tested in the REVERSE (REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction) study (7) . The overall results confirm that CRT induces reverse LV remodeling and delays the time to first HF-related hospitalization over 12 months with further improvement over time (8) . It has been suggested that the response by CRT treatment is affected by etiology, in particular regarding reverse remodeling (9 -11) . The aim of this report was to study the REVERSE results in relation to nonischemic compared with ischemic HF etiology.
Methods
Patient population. Eligible patients had American College of Cardiology/American Heart Association stage C (7), NYHA functional class I or II HF with QRS duration Ն120 ms, left ventricular ejection fraction (LVEF) Յ40%, and LV end-diastolic diameter Ն55 mm. Ischemic heart disease (IHD) was defined as a history of myocardial infarction or coronary revascularization and/or evidence of 2-or 3-vessel disease by coronary angiography and non-IHD as the absence of these criteria. Study design, procedures, and end points. Patients were assessed at baseline, underwent implantation, and randomly assigned to active CRT (CRT-ON) or to control (CRT-OFF) Ϯ implantable cardioverter-defibrillator and evaluated at 1, 3, 6, and 12 months in a double-blind fashion (7). The primary end point was the percentage of patients worsened by the HF clinical composite response (7) . Left ventricular end-systolic volume index (LVESVi) was the prospectively powered secondary end point. Statistical methods. All results were analyzed according to the intention-to-treat principle. All p values reported are nominal, and all statistical tests are 2 sided. Kaplan-Meier analysis was used to analyze time to first HF hospitalization. The log-rank test was used to assess significance. Student's t test was used for comparisons of means, and the Fisher exact test was used to compare proportions. Randomization, etiology, and their interaction were examined for secondary end points using analysis of variance methods. A logistic regression model was used for multivariable analysis of the clinical composite response at 12 months and a regression model for change in the LVESVi from baseline to 12 months. Backward stepwise elimination was used to reduce the model to factors with p values Ͻ0.05. Baseline factors considered were randomization group, etiology, age, sex, NYHA functional class, systolic blood pressure, LVEF, LVESVi, left bundle branch block (LBBB), baseline QRS duration, at least 50% target dose of beta-blockers, glomerular filtration rate, diabetes, history of hypertension, coronary artery bypass graft, and previous percutaneous coronary intervention. (Table 1) show that the 277 IHD patients were significantly older and had more comorbidities than the 333 non-IHD patients. LVEF was significantly higher in IHD compared with non-IHD patients. Non-IHD patients more often were female, less often received a concomitant implantable cardioverter-defibrillator, had larger LV dimensions, wider QRS width, and longer intraventricular mechanical delay duration (Table 1) . LBBB was significantly more frequent in non-IHD patients. IHD patients less often received at least 50% of the target dose of beta-blockers. Effects on primary and secondary end points at 12 months. Compared with control, CRT significantly reduced the percentage of patients worsened by the HF composite response in non-IHD patients but not in IHD patients ( (Fig. 2) . In an analysis of variance model, randomization (p Ͻ 0.0001), etiology (p Ͻ 0.0001), and their interaction (p ϭ 0.045) were all predictors of LVESVi change over 12 months (Table 2 ). In the non-IHD group, LVEF significantly improved by 7.5 Ϯ 9.3% in the CRT-ON group after 12 months compared with 1.4 Ϯ 7.2% in CRT-OFF group (p Ͻ 0.0001). In the IHD group, it improved by 2.2 Ϯ 8.5% in CRT-ON compared with 0.3 Ϯ 6.0% in CRT-OFF (p ϭ 0.03). The change in LVEF was associated with randomization (p Ͻ 0.0001), etiology (p Ͻ 0.0001) and the interaction between the 2 (p Ͻ 0.008).
Results

Study population. Baseline characteristics
In non-IHD patients, CRT significantly improved the Minnesota Living With Heart Failure Quality of Life Questionnaire score, whereas the 6-min walk distance was unaffected ( Table 2 ). Among baseline NYHA functional class II patients, 43% of CRT-ON non-IHD patients improved to NYHA functional class I compared with 32% of CRT-OFF patients (p ϭ 0.09). In NYHA functional class II IHD patients, 35% of CRT-ON patients improved to NYHA functional class I compared with 20% of CRT-OFF patients (p ϭ 0.02). In a logistic regression model, the interaction term of randomization and NYHA functional class was not significant (p ϭ 0.52). HF hospitalizations. The time to first HF hospitalization is shown in Figure 3 . The overall morbidity in both randomization arms was larger in ischemic patients than in nonischemic patients, reflecting the older age and the greater baseline morbidity in the IHD patients. Non-IHD patients had a 5.3% HF hospitalization rate over 12 months in the CRT-OFF group compared with 2.9% in the CRT-ON group. The corresponding rates for IHD patients were 10.3% and 5.0%, respectively. The difference in time to The results of models for independent predictors of both clinical composite response and change in LVESVi are shown in Table 3 . History of LBBB was a significant predictor of response to both end points as was randomization (to CRT) and baseline QRS duration (long rather than short). Age was an independent predictor only for clinical response, and etiology was an independent predictor only for LVESVi. Even when age was removed from the model, etiology still was not a predictor of clinical composite response (p ϭ 0.52). Interaction of randomization and etiology with the other significant predictors was examined by individually adding these terms into the models. No interaction terms were significant when added into the clinical composite response model; however, in the LVESVi model, all 4 predictors interacting with randomization were significant, as well as etiology with LVEF and QRS duration.
Discussion
The major finding of this substudy of REVERSE was that the extent of reverse remodeling was greater in non-IHD patients. Our findings concur with results from earlier CRT studies of NYHA functional class III/IV HF patients (5,6).
We previously reported a significant correlation between electrical and mechanical dyssynchrony and reverse remodeling in REVERSE (12) . It is possible that the lesser degree of dyssynchrony in IHD patients partly explained the less extent of reverse remodeling by CRT. Indeed, LBBB and QRS duration were multivariate predictors of reverse remodeling by CRT, but IHD etiology was not. It can also be speculated that CRT is less effective when contractility is impaired by extensive myocardial scar tissue, even in the presence of conduction delay. This could reflect the less "plasticity" of myocardial scar tissue to both dilate and shrink and confirms previous CRT study results in NYHA functional class III/IV patients (9 -11) . A further reason could be that IHD patients in REVERSE were older and had more comorbidities. When these factors were assessed in a logistic regression model, LBBB, longer baseline QRS, and randomization to CRT were the only independent predictors of response in the primary end point, but HF etiology was not, indicating that clinical benefits of CRT Effect of Etiology on CRT in Mild Heart Failure occurred irrespective of age and etiology. These results agree with those of the CARE-HF (CArdiac REsynchronization in Heart Failure) study in which the clinical benefit was similar in non-IHD and IHD patients despite less reverse LV remodeling, more advanced age, and more comorbidities in IHD patients. As in REVERSE, etiology was not an independent predictor of response to CRT by multivariable analysis (10) . Our study suggests that LBBB and baseline QRS duration are important determinants of response to CRT in mild HF beyond reverse remodeling.
Patient Characteristics in Nonischemic and Ischemic Patients
12-Month Results by Randomization in the Non-IHD and IHD Groups and Their Interaction by Regression Model
The treatment goal in mild HF strives to keep patients as long as possible from worsening. REVERSE was the first randomized, controlled CRT study with this perspective but was not designed to study morbidity and mortality. MADIT-CRT (The Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy) (13) found a significant reduction in HF events predominantly by reduction of HF hospitalization independent of etiology or age but restricted to patients with baseline QRS duration of at least 150 ms. The results from MADIT-CRT CRT ϭ cardiac resynchronization therapy; HF ϭ heart failure; HR ϭ hazard ratio. The p values are for factor effect in a multivariable logistic regression model for clinical composite score at 12 months and a multivariable regression model for change in LVESVi from baseline to 12 months. For dichotomous variables, the state more likely to see improvement is indicated. CI ϭ confidence interval; LBBB ϭ left bundle branch block; LVEF ϭ left ventricular ejection fraction; NYHA ϭ New York Heart Association; other abbreviations as in Table 2 .
Assessment of Independent Predictors of Response
are very concurrent with the REVERSE results and most likely over time will translate into a wider use of CRT in mildly symptomatic patients to prevent disease progression. Study limitations. The multivariable models included 16 terms that were believed to be potentially predictive of results. Inclusion of this many terms may result in overfitting of the models.
Conclusions
This substudy of REVERSE shows that CRT reverses LV remodeling with a more extensive effect in non-IHD patients. Etiology was, however, not an independent predictor of clinical response. Longer observation periods and larger patient groups are needed to firmly determine the influence of etiology on CRT response.
